Vaccine rollout faces delays as authorities scramble to secure alternatives to AstraZeneca such as Pfizer for under-50s over blood clot fears. Follow updates live
- Australia issues blood clot warning for AstraZeneca vaccine for under-50s
- Aged care nurses still in the dark about promised ‘pop-up’ vaccination hubs
- Follow our global coronavirus live blog
Offical morning coffee game ruling: ADOPTED
@matildaboseley can we sip for “an abundance of caution”?#guardiancoffeedrinkinggame
The AstraZeneca advisory warning could be reconsidered if Australia experiences a large outbreak, says the co-chair of the Australian Technical Advisory Group on Immunisation, Prof Allen Cheng.
In a lengthy (and very helpful) Twitter threat last night explaining the ATAGI decision, Cheng said if cases of Covid-19 rose in Australia the risk-benefit balance would change, suggesting the AZ could once again be recommended for people under 50.
If we had a large outbreak, then this risk benefit analysis would change and we'd have to reconsider this advice. The risk benefit balance would also be different in countries with even larger outbreaks than the UK.
Continue reading...from The Guardian https://ift.tt/3t5rTsN
